NCT03077191View on ClinicalTrials.gov

Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy: a Single Institution Experience

Active, not recruitingOBSERVATIONAL

Enrollment

410

Participants

Timeline

Start Date

November 1, 2016

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2026

Conditions

Breast CancerQuality of LifeRadiotherapy; Adverse Effect, Dermatitis or EczemaSurvivorship

Interventions

OTHER

Quality of life measurement

The quality of life of breast cancer patients treated with conservative surgery and adjuvant whole breast hypofractionated radiotherapy, without boost, will be evaluated.

Trial Locations (1)

20132

IRCCS San Raffaele Scientific Institute, Milan

All Listed Sponsors

lead

IRCCS San Raffaele

OTHER

NCT03077191 - Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy: a Single Institution Experience | Biotech Hunter | Biotech Hunter